Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andreas Neubauer

Showing results (131-140 of 224) with videos related to

Pageof 23
Sort By:
Frontiers in Oncology|March 26, 2026
Case Report: Pregnant ROS1+ lung cancer patient treated with crizotinib - Impact on infancyTheresa Weber, Jörg Hoffmann, Christian Michel, et al.
Leukemia|August 13, 2021
The janus-kinase inhibitor ruxolitinib in SARS-CoV-2 induced acute respiratory distress syndrome (ARDS)Andreas Neubauer, Johannes Johow, Elisabeth Mack, et al.
Leukemia|April 6, 2023
In vivo kinetics of early, non-random methylome and transcriptome changes induced by DNA-hypomethylating treatment in primary AML blastsGabriele Greve, Geoffroy Andrieux, Pascal Schlosser, et al.
Cancer Research|September 1, 2018
Development, Function, and Clinical Significance of Plasmacytoid Dendritic Cells in Chronic Myeloid LeukemiaSabrina Inselmann, Ying Wang, Susanne Saussele, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 11, 2018
Outcome of Patients With Early-Stage Infradiaphragmatic Hodgkin Lymphoma: A Comprehensive Analysis From the German Hodgkin Study GroupStephanie Sasse, Helen Goergen, Annette Plütschow, et al.
Frontiers in Medicine|June 9, 2023
Serum proteomics hint at an early T-cell response and modulation of SARS-CoV-2-related pathogenic pathways in COVID-19-ARDS treated with RuxolitinibSara Völkel, Thomas S Tarawneh, Laura Sacher, et al.
Leukemia|October 7, 2025
Genetic and epigenetic alterations at secondary resistance after continued decitabine-based treatment of acute myeloid leukemia in the randomized phase II DECIDER trialInga Hund, Maria Elena Hess, Geoffroy Andrieux, et al.
Annals of Hematology|January 21, 2026
PRDM16 expression is an independent prognostic factor in AML with the double-mutant NPM1/FLT3-ITD genotypeSebastian Stasik, Jan-Niklas Eckardt, Christoph Röllig, et al.
American Journal of Hematology|March 10, 2025
Allogeneic Hematopoietic Cell Transplantation in Patients With Acute Myeloid Leukemia With Myelodysplasia-Related Genetic Features: Relevance of the Genetic Underlying Category. A Retrospective Analysis on Behalf of the Acute Leukemia Working Party of the EBMTJordi Esteve, Arnon Nagler, Myriam Labopin, et al.
British Journal of Haematology|March 19, 2016
Single versus tandem high-dose melphalan followed by autologous blood stem cell transplantation in multiple myeloma: long-term results from the phase III GMMG-HD2 trialElias K Mai, Axel Benner, Uta Bertsch, et al.
Pageof 23

Showing results (131-140 of 224) with videos related to

Sort By:
Pageof 23
Frontiers in Oncology|March 26, 2026
Case Report: Pregnant ROS1+ lung cancer patient treated with crizotinib - Impact on infancyTheresa Weber, Jörg Hoffmann, Christian Michel, et al.
Leukemia|August 13, 2021
The janus-kinase inhibitor ruxolitinib in SARS-CoV-2 induced acute respiratory distress syndrome (ARDS)Andreas Neubauer, Johannes Johow, Elisabeth Mack, et al.
Leukemia|April 6, 2023
In vivo kinetics of early, non-random methylome and transcriptome changes induced by DNA-hypomethylating treatment in primary AML blastsGabriele Greve, Geoffroy Andrieux, Pascal Schlosser, et al.
Cancer Research|September 1, 2018
Development, Function, and Clinical Significance of Plasmacytoid Dendritic Cells in Chronic Myeloid LeukemiaSabrina Inselmann, Ying Wang, Susanne Saussele, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 11, 2018
Outcome of Patients With Early-Stage Infradiaphragmatic Hodgkin Lymphoma: A Comprehensive Analysis From the German Hodgkin Study GroupStephanie Sasse, Helen Goergen, Annette Plütschow, et al.
Frontiers in Medicine|June 9, 2023
Serum proteomics hint at an early T-cell response and modulation of SARS-CoV-2-related pathogenic pathways in COVID-19-ARDS treated with RuxolitinibSara Völkel, Thomas S Tarawneh, Laura Sacher, et al.
Leukemia|October 7, 2025
Genetic and epigenetic alterations at secondary resistance after continued decitabine-based treatment of acute myeloid leukemia in the randomized phase II DECIDER trialInga Hund, Maria Elena Hess, Geoffroy Andrieux, et al.
Annals of Hematology|January 21, 2026
PRDM16 expression is an independent prognostic factor in AML with the double-mutant NPM1/FLT3-ITD genotypeSebastian Stasik, Jan-Niklas Eckardt, Christoph Röllig, et al.
American Journal of Hematology|March 10, 2025
Allogeneic Hematopoietic Cell Transplantation in Patients With Acute Myeloid Leukemia With Myelodysplasia-Related Genetic Features: Relevance of the Genetic Underlying Category. A Retrospective Analysis on Behalf of the Acute Leukemia Working Party of the EBMTJordi Esteve, Arnon Nagler, Myriam Labopin, et al.
British Journal of Haematology|March 19, 2016
Single versus tandem high-dose melphalan followed by autologous blood stem cell transplantation in multiple myeloma: long-term results from the phase III GMMG-HD2 trialElias K Mai, Axel Benner, Uta Bertsch, et al.
Pageof 23